- Home
- NAMS vs FBP Comparison
NAMS vs FBP Comparison
Compare NAMS & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAMS | FBP |
|---|---|---|
| Founded | 2019 | 1948 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2022 | 2010 |
Fundamental Metrics
Financial Performance| Metric | NAMS | FBP |
|---|---|---|
| Price | $27.93 | $29.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $46.75 | $25.50 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | ★ 32.81 | 18.78 |
| EPS | N/A | ★ 1.19 |
| Revenue | $22,503,000.00 | ★ $1,255,034,000.00 |
| Revenue This Year | $17.96 | $15.10 |
| Revenue Next Year | $540.65 | $4.65 |
| P/E Ratio | ★ N/A | $24.40 |
| Revenue Growth | N/A | ★ 2.38 |
| 52 Week Low | $23.05 | $19.16 |
| 52 Week High | $42.21 | $29.42 |
Technical Indicators
Market Signals| Indicator | NAMS | FBP |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 67.67 |
| Support Level | $25.74 | $20.55 |
| Resistance Level | $37.29 | $29.42 |
| Average True Range (ATR) | 1.37 | 0.44 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 36.04 | 80.38 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Mortgage Banking; Consumer (Retail) Banking; Commercial and Corporate Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. The Consumer (Retail) Banking segment generates the majority of revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.